US Starting Stem Cell Trial For Blindness

US Starting Stem Cell Trial For Blindness

A US company will test human embryonic stem cells to treat blindness in a bid to examine how the controversial procedure works in humans. Advanced Cell Technology, a California-based biotech company, announced the planned test on Monday, the second such clinical trial.

Bob Lanza, chief scientific officer at Advanced Cell Technology said that the process has been tested on rats and mice and has been found to halt the progressive disease without causing tumors or other side effects. “These cells have been really performing quite spectacularly in the animals. If we can see that in the human patients we will hit a home run here,” Lanza said.

The trial was allowed to go ahead after the US Food and Drug Administration cleared its application to start a phase I study.

Related Posts with Thumbnails

1 Comments For This Post

  1. europeanbiotech Says:

    IPS research along with its therapeutic potential is very promising technology for treating all types of diseases. Unfortunately there is much controversy associated with the field which stems mainly from confusing embryonic stem cells with IPSs.

    One interesting story that came out this week was a German’s groups finding that amniotic cells can be converted into IPSs. This is a wonderful finding since amniotic cells are abundantly available and are quite uncontroversial. You can see the full story here: converting amniotic cells into stem cells

Leave a Reply

Contact Us

Tips, Leads, Suggestions, Just Want to Say Hello? Email Dan or Sarah at support (at) stemcellumbilicalcordblood (dot) com